Connect your AI

Madrigal Pharmaceuticals, Inc. MDGL Professional fees

Professional fees at other companies

EvercoreEVR

$27.54M+30.2%

UMB FinancialUMBF

$9.09M-68.2%

KKR & Co.KKR

$26.4M+18.2%

The Carlyle GroupCG

-$25M-125%

PopularBPOP

——

PopularBPOP

——

Segments

By segment

Reportable Segment$131.25M+49.1%

Other financials

Income statement

Revenue$311.3M+127%

Gross profit$43.5M—

Operating income-$92.7M-16.9%

Net income-$94.4M-28.9%

EPS (diluted)-$3.25-24.5%

Balance sheet

Cash & equivalents$232.2M+23.1%

Total debt$377.3M+187%

Total equity$543.5M-23.5%

Total assets$1.2B+23.1%

Cash flow

Operating cash flow-$167.4M-88.4%

CapEx$3.8M—

Free cash flow-$171.3M-92.7%

Valuation

Market cap$11.66B+64.2%

Enterprise value$11.81B+67.5%

P/S10.3×-12.1×

Profitability

Gross margin96.5%—

Operating margin-27.7%-12.2pp

Net margin-27.3%-12.0pp

FCF margin-59.8%-29.6pp

Returns & leverage

Return on equity-49.3%-0.8pp

Debt / equity0.7×+0.5×

Current ratio3.5×-2.4×